Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma.

Peak, Taylor C; Fenu, Elena M; Rothberg, Michael B; Thomas, Christopher Y; Davis, Ronald L; Levine, Edward A

Peak, Taylor C; Fenu, Elena M; Rothberg, Michael B; Thomas, Christopher Y; Davis, Ronald L; Levine, Edward A.

Afiliação

Peak TC; Department of Urology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Fenu EM; Department of Pathology, Wake Forest Baptist Medical Center, Winston-Salem NC, USA.
Rothberg MB; Department of Urology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Thomas CY; Department of Medical Oncology and Hematology, Wake Forest Baptist Medical Center, Winston-Salem NC, USA.
Davis RL; Department of Urology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Levine EA; Surgical Oncology Service, Department of General Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.

Case Rep Urol ; 2020: 8846135, 2020.

Article em En | MEDLINE | ID: mdl-33204569

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article